跳至主要内容
临床试验/NCT07630857
NCT07630857招募中不适用

Unipolar Mapping for Personalized Atrial Fibrillation Ablation: An Interventional Study on Arrhythmia Maintenance and Atrial Remodeling

China National Center for Cardiovascular Diseases1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2026年6月20日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
1

研究概览

简要总结

Atrial fibrillation (AF) is a common heart rhythm disorder. While catheter ablation is an effective treatment, many patients still experience AF recurrence after the procedure. One major reason is that the mechanisms that maintain AF are not fully understood. Research suggests that the outer layer of the heart (epicardium) may play an important role in keeping AF going. However, current mapping techniques have limitations in detecting electrical signals from both the inner and outer heart layers.

This study uses a different technique called unipolar voltage mapping, which may more accurately capture electrical signals from both heart layers. Specifically, we focus on a specific type of electrical signal called "QS potential" on unipolar mapping, which reflects breakthrough sites between the inner and outer heart layers.

In this interventional study, participants with AF undergoing catheter ablation will receive personalized ablation guided by unipolar QS-potential mapping. We aim to:

Explore the relationship between unipolar QS-potentials and AF maintenance and atrial remodeling Evaluate the effectiveness of QS-potential guided personalized AF ablation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years and ≤ 80 years
  • Documented diagnosis of atrial fibrillation (paroxysmal or persistent)
  • Planned to undergo catheter ablation for AF (including patients with recurrent AF after prior ablation)
  • Able and willing to provide written informed consent
  • Able to complete scheduled follow-up visits (3 months post-ablation)

排除标准

  • Left ventricular ejection fraction < 35%
  • Severe valvular heart disease (moderate to severe mitral stenosis or regurgitation)
  • History of intracardiac thrombus
  • Contraindication to anticoagulation
  • Active infection or sepsis
  • Pregnancy or breastfeeding
  • Life expectancy < 12 months due to comorbid conditions
  • Participation in another interventional clinical trial within 30 days prior to enrollment

研究组 & 干预措施

QS-Guided Ablation Group

Experimental

Participants in this arm undergo catheter ablation for atrial fibrillation guided by unipolar QS-potential mapping. Ablation is delivered to these identified target sites in addition to standard pulmonary vein isolation.

干预措施: Unipolar QS-Potential Guided Catheter Ablation (Procedure)

Conventional PVI Group

Other

Participants in this arm undergo conventional pulmonary vein isolation for atrial fibrillation using standard bipolar voltage mapping. Ablation is performed to achieve electrical isolation of the pulmonary veins, without additional mapping-guided ablation beyond PVI.

干预措施: Conventional Pulmonary Vein Isolation (Procedure)

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Yuhe Jia

Chief Physician, Department of Cardiology

China National Center for Cardiovascular Diseases

研究点 (1)

Loading locations...

相似试验